Skip to content
ppharmaranks
Menu

CIMERLI vs VABYSMO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. CIMERLI and VABYSMO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

68/100
70/100

Pharmacy pays

Type

RX
RX

Active ingredient

RANIBIZUMAB-EQRN
FARICIMAB-SVOA

Dosage forms

Injectable
Injectable

Drug class

Boxed warning

None
None

Treats

Diabetic Retinopathy, Macular Edema, Retinal Vein Occlusion
Diabetic Retinopathy, Macular Degeneration

Frequently asked questions

Which is better-rated, Cimerli or Vabysmo?

By our independent rating, Vabysmo scores higher — 3.5 vs 3.4 out of 5 for Cimerli. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Cimerli and Vabysmo?

Cimerli contains Ranibizumab-Eqrn, while Vabysmo contains Faricimab-Svoa — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.